ITALICA at PAN 2013: An Ensemble Learning Approach to Author Profiling Notebook for PAN at CLEF 2013

This notebook discusses the approach to the Author Profiling task developed by the Italica group for PAN 2013. This system implements two different sets of classifiers which are combined later in order to build a final classifier that takes into account the decisions of the previous ones. The initial classifiers are focused on vector space representations of the documents as a bag of words and n-grams of POS tags and also on a set of stylistic features of the texts. The final classifier consists of a stacking schema that combines the other ones. This approach has obtained better results for the Spanish dataset than for the English dataset, probably due to the use of more detailed POS tagset in the forme

An AFM Approach of RBC Micro and Nanoscale Topographic Features During Storage

Blood gamma irradiation is the only available method to prevent transfusion-associated graft versus host disease (TA-GVHD). However, when blood is irradiated, determine blood shelf time is crucial. Non-irradiated blood has a self-time from 21 to 35 days when is preserved with an anticoagulated solution and stored at 4°C. During their storage, red blood cells (RBC) undergo a series of biochemical, biomechanical and molecular changes involving what is known as storage lesion (SL). SL include loss of structural integrity of RBC, a decrease of 2,3-diphosphatidylglyceric acid levels, and an increase of both ion potassium concentration and hemoglobin (Hb). On the other hand, Atomic force Microscopy (AFM) represents a versatile tool for a nano-scale high-resolution topographic analysis in biological systems. In order to evaluate SL in irradiated and non-irradiated blood, RBC topography and morphometric parameters were obtained from an AFM XE-BIO system. Cell viability was followed using flow cytometry. Our results showed that early markers as nanoscale roughness, allow us to evaluate blood quality since another perspective

Wireless Sensor Network Deployment for Monitoring Wildlife Passages

Wireless Sensor Networks (WSNs) are being deployed in very diverse application scenarios, including rural and forest environments. In these particular contexts, specimen protection and conservation is a challenge, especially in natural reserves, dangerous locations or hot spots of these reserves (i.e., roads, railways, and other civil infrastructures). This paper proposes and studies a WSN based system for generic target (animal) tracking in the surrounding area of wildlife passages built to establish safe ways for animals to cross transportation infrastructures. In addition, it allows target identification through the use of video sensors connected to strategically deployed nodes. This deployment is designed on the basis of the IEEE 802.15.4 standard, but it increases the lifetime of the nodes through an appropriate scheduling. The system has been evaluated for the particular scenario of wildlife monitoring in passages across roads. For this purpose, different schemes have been simulated in order to find the most appropriate network operational parameters. Moreover, a novel prototype, provided with motion detector sensors, has also been developed and its design feasibility demonstrated. Original software modules providing new functionalities have been implemented and included in this prototype. Finally, main performance evaluation results of the whole system are presented and discussed in depth

Intranasal DNA vaccine for protection against respiratory infectious diseases: the delivery perspectives

published_or_final_versio

IDENTIFICACIÓN DE LA INTERACCIÓN DE MONOCITOS HUMANOS CON LAS LECTINAS DE Olneya tesota (IF2) Y Phaseolus vulgaris (PHA-L) POR CITOMETRÍA DE FLUJO

En este estudio se purificaron tres isolectinas (IF1, IF2 e IF3) de la lectina de palo fierro (PF2) a partir de las semillas de Olneya tesota, usando cromatografía de afinidad, seguida de intercambio iónico. La isoforma más abundante de PF2 (IF2) y la lectina de frijol PHA-L se utilizaron para identificar el patrón de reconocimiento hacia células mononucleares de sangre periférica humana por citometría de flujo. Todos los tipos sanguíneos (ABO) presentaron un perfil de reconocimiento similar por las lectinas. En particular, las estructuras oligosacáridas de los monocitos circulantes fueron reconocidas por IF2 y PHA-L con mayor intensidad que el resto de las células. Los linfocitos B y T presentaron una menor interacción con IF2 que con PHA-L. Los receptores carbohidrato de IF2 pudieran ser usados como marcadores potenciales de monocitos en patologías asociadas con estas células

Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model

Abstract Background Using killed microorganisms or their parts to stimulate immunity for cancer treatment dates back to the end of 19th century. Since then, it undergone considerable development. Our novel approach binds ligands to the tumor cell surface, which stimulates tumor phagocytosis. The therapeutic effect is further amplified by simultaneous application of agonists of Toll-like receptors. We searched for ligands that induce both a strong therapeutic effect and are safe for humans. Methods B16-F10 murine melanoma model was used. For the stimulation of phagocytosis, mannan or N-formyl-methionyl-leucyl-phenylalanine, was covalently bound to tumor cells or attached using hydrophobic anchor. The following agonists of Toll-like receptors were studied: monophosphoryl lipid A (MPLA), imiquimod (R-837), resiquimod (R-848), poly(I:C), and heat killed Listeria monocytogenes. Results R-848 proved to be the most suitable Toll-like receptor agonist for our novel immunotherapeutic approach. In combination with covalently bound mannan, R-848 significantly reduced tumor growth. Adding poly(I:C) and L. monocytogenes resulted in complete recovery in 83% of mice and in their protection from the re-transplantation of melanoma cells. Conclusion An efficient cancer treatment results from the combination of Toll-like receptor agonists and phagocytosis stimulating ligands bound to the tumor cells.http://deepblue.lib.umich.edu/bitstream/2027.42/134739/1/12885_2016_Article_2982.pd

A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8+ T Cells

The most effective strategy for protection against intracellular infections such as Leishmania is vaccination with live parasites. Use of recombinant proteins avoids the risks associated with live vaccines. However, due to low immunogenicity, they fail to trigger T cell responses particularly of CD8+cells requisite for persistent immunity. Previously we showed the importance of protein entrapment in cationic liposomes and MPL as adjuvant for elicitation of CD4+ and CD8+ T cell responses for longterm protection. In this study we investigated the role of cationic liposomes on maturation and antigen presentation capacity of dendritic cells (DCs). We observed that cationic liposomes were taken up very efficiently by DCs and transported to different cellular sites. DCs activated with liposomal rgp63 led to efficient presentation of antigen to specific CD4+ and CD8+ T cells. Furthermore, lymphoid CD8+ T cells from liposomal rgp63 immunized mice demonstrated better proliferative ability when co-cultured ex vivo with stimulated DCs. Addition of MPL to vaccine enhanced the antigen presentation by DCs and induced more efficient antigen specific CD8+ T cell responses when compared to free and liposomal ntigen. These liposomal formulations presented to CD8+ T cells through TAP-dependent MHC-I pathway offer new possibilities for a safe subunit vaccine

Trace Levels of Innate Immune Response Modulating Impurities (IIRMIs) Synergize to Break Tolerance to Therapeutic Proteins

Therapeutic proteins such as monoclonal antibodies, replacement enzymes and toxins have significantly improved the therapeutic options for multiple diseases, including cancer and inflammatory diseases as well as enzyme deficiencies and inborn errors of metabolism. However, immune responses to these products are frequent and can seriously impact their safety and efficacy. Of the many factors that can impact protein immunogenicity, this study focuses on the role of innate immune response modulating impurities (IIRMIs) that could be present despite product purification and whether these impurities can synergize to facilitate an immunogenic response to therapeutic proteins. Using lipopolysaccharide (LPS) and CpG ODN as IIRMIs we showed that trace levels of these impurities synergized to induce IgM, IFNγ, TNFα and IL-6 expression. In vivo, trace levels of these impurities synergized to increase antigen-specific IgG antibodies to ovalbumin. Further, whereas mice treated with human erythropoietin showed a transient increase in hematocrit, those that received human erythropoietin containing low levels of IIRMIs had reduced response to erythropoietin after the 1st dose and developed long-lasting anemia following subsequent doses. This suggests that the presence of IIRMIs facilitated a breach in tolerance to the endogenous mouse erythropoietin. Overall, these studies indicate that the risk of enhancing immunogenicity should be considered when establishing acceptance limits of IIRMIs for therapeutic proteins